Evidence map›Paper›PMID 24482177›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2014

Proliferation assays (BrdU and EdU) on skeletal tissue sections.

Timothy J Mead, Véronique Lefebvre

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 115 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. STK32C promotes colon tumor progression through activating c-MYC signaling.Cellular and molecular life sciences : CMLS · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. CBX4 Regulates Replicative Senescence of WI-38 Fibroblasts.Oxidative medicine and cellular longevity · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Timothy J MeadCleveland Clinic Lerner Research Institute, Cleveland, OH, USA.
Véronique LefebvreCleveland Clinic Lerner Research Institute, Cleveland, OH, USA.
Cleveland Clinic Lerner College of Medicine · US

Funding

Sox9-mediated control of chondrogenesisR01AR046249 · NIAMS · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI LEFEBVRE, VERONIQUE M · 1999 to 2015
$4.9M
Transcriptional Control of Sox9R01AR060016 · NIAMS · CLEVELAND CLINIC LERNER COM-CWRU · PI LEFEBVRE, VERONIQUE M · 2010 to 2014
$2.2M
ROLES OF SOX C GENES IN SKELETOGENESISR01AR054153 · NIAMS · CLEVELAND CLINIC LERNER COM-CWRU · PI LEFEBVRE, VERONIQUE M · 2006 to 2010
$1.6M
NIAMS NIH HHS AR46249NIAMS NIH HHS R01 AR046249NIAMS NIH HHS R01 AR054153NIAMS NIH HHS R01 AR060016PHS HHS 54153PHS HHS 60016
6 · The paper itself

Abstract

Assessing cell proliferation in situ is an important phenotyping component of skeletal tissues from development to adult stages and disease. Various methods exist including immunostaining for proteins and protein modifications associated with specific steps of the cell cycle, but the gold standard is to quantify the percentage of DNA-synthesizing cells. The thymidine analog 5-bromo-2'-deoxyuridine (BrdU) has been widely used in the last decades for this purpose, with the inconvenience that its detection is lengthy and requires harsh treatment of tissue sections to give access of anti-BrdU antibody to nucleosides in genomic DNA. In 2008, Salic and Mitchison developed a new method and proved it to be quicker, simpler, and highly sensitive in non-skeletal tissues. This method relies on incorporation of 5-ethynyl-2'-deoxyuridine (EdU) into de novo DNA. This other thymidine analog is readily detected by click chemistry, i.e., covalent cross-linking of its ethynyl group with a fluorescent azide, a molecule small enough to diffuse freely through native tissues and DNA. Here, we describe and compare the BrdU and EdU approaches in skeletal tissues and conclude that in these tissues too EdU provides an easy and very sensitive alternative to BrdU.

Indexed as

BromodeoxyuridineDeoxyuracil NucleotidesAnimalsBone and BonesIn Situ HybridizationMiceMicroscopyStaining and Labeling2'-deoxy-5-ethyl-5'-uridylic acidBromodeoxyuridineDeoxyuracil Nucleotides

Identifiers

PMID24482177
PMCPMC4074019
OpenAlexW2277563293

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.